Detalhe da pesquisa
1.
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma.
Br J Haematol
; 204(2): 514-524, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37853658
2.
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Blood
; 139(5): 732-747, 2022 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34653238
3.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38385243
4.
Lymphomas in pregnancy.
Hematol Oncol
; 41 Suppl 1: 70-74, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37294956
5.
CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival.
Radiol Med
; 128(12): 1497-1507, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37752299
6.
Bacterial infection-driven lymphomagenesis.
Curr Opin Oncol
; 34(5): 454-463, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35880463
7.
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Hematol Oncol
; 40(1): 11-21, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34714558
8.
Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK).
Br J Haematol
; 192(6): 1031-1034, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32805081
9.
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study.
Ann Hematol
; 100(7): 1743-1753, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33774681
10.
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study.
Eur J Haematol
; 104(6): 581-587, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32107795
11.
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome.
Br J Haematol
; 187(4): 478-487, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31385291
12.
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer.
Curr Oncol Rep
; 21(2): 13, 2019 02 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30715616
13.
Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.
Chemotherapy
; 64(2): 110-114, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31533095
14.
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma.
Haematologica
; 108(6): 1671-1675, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36546422
15.
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.
Chemotherapy
; 63(4): 220-224, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30372691
16.
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.
Hematol Oncol
; 40(5): 1100-1104, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35613703
17.
Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma.
Hum Vaccin Immunother
; 20(1): 2309701, 2024 Dec 31.
Artigo
Inglês
| MEDLINE | ID: mdl-38299612
18.
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.
Blood Adv
; 8(6): 1541-1549, 2024 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38181782
19.
Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma.
Hemasphere
; 6(6): e727, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35747846
20.
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study.
Cancers (Basel)
; 14(4)2022 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35205765